SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Parshall B Lynne – ‘4’ for 12/26/23 re: Ionis Pharmaceuticals Inc.

On:  Thursday, 12/28/23, at 7:18pm ET   ·   For:  12/26/23   ·   As:  Director   ·   Accession #:  874015-23-241   ·   File #:  0-19125

Previous ‘4’:  ‘4’ on 9/28/23 for 9/26/23   ·   Latest ‘4’:  This Filing

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/28/23  Parshall B Lynne                  4          Director    1:14K  Ionis Pharmaceuticals Inc.        Ionis Pharmas Inc.

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML     14K 
                Securities by an Insider -- edgardoc.xml/5.8


        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
SEC Info℠ rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 

The SEC has not released XSLT Stylesheets needed to render this File’s XML Data as a Form.

This is our “Plain Text” rendering:
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0508
Document Type:  4
Period of Report:  12/26/23
Not Subject to Section 16:  0
Issuer:
Issuer CIK:  874015
Issuer Name:  IONIS PHARMACEUTICALS INC
Issuer Trading Symbol:  IONS
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1073385
Owner Name:  PARSHALL B LYNNE
Reporting Owner Address:
Owner Street 1:  2855 GAZELLE COURT
Owner Street 2:
Owner City:  CARLSBAD
Owner State:  CA
Owner ZIP Code:  92010
Owner State Description:
Reporting Owner Relationship:
Is Director?  Yes
Is Officer?  No
Is Ten Percent Owner?  No
Is Other?  No
Aff 10b5 One:  1
Non-Derivative Table:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  12/26/23
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  M
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  25,113
Transaction Price Per Share:
Value:  47.34
Transaction Acquired-Disposed Code:
Value:  A
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  107,701
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  12/26/23
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  S
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  25,113
Transaction Price Per Share:
Value:  51.463
Footnote ID:  F1
Transaction Acquired-Disposed Code:
Value:  D
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  82,588
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  12/27/23
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  M
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  50,000
Transaction Price Per Share:
Value:  47.34
Transaction Acquired-Disposed Code:
Value:  A
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  132,588
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  12/27/23
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  S
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  50,000
Transaction Price Per Share:
Value:  50.2303
Footnote ID:  F2
Transaction Acquired-Disposed Code:
Value:  D
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  82,588
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  12/28/23
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  M
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  42,525
Transaction Price Per Share:
Value:  47.34
Transaction Acquired-Disposed Code:
Value:  A
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  125,113
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  12/28/23
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  S
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  42,525
Transaction Price Per Share:
Value:  50.1875
Footnote ID:  F3
Transaction Acquired-Disposed Code:
Value:  D
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  82,588
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Table:
Derivative Transaction:
Security Title:
Value:  Non-Qualified Stock Option (right to buy)
Conversion or Exercise Price:
Value:  47.34
Transaction Date:
Value:  12/26/23
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  M
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  25,113
Transaction Price Per Share:
Value:  0.0
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Value:  1/3/19
Expiration Date:
Value:  1/2/24
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  25,113
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  92,525
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Non-Qualified Stock Option (right to buy)
Conversion or Exercise Price:
Value:  47.34
Transaction Date:
Value:  12/27/23
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  M
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  50,000
Transaction Price Per Share:
Value:  0.0
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Value:  1/3/20
Expiration Date:
Value:  1/2/24
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  50,000
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  42,525
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Non-Qualified Stock Option (right to buy)
Conversion or Exercise Price:
Value:  47.34
Transaction Date:
Value:  12/28/23
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  M
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  42,525
Transaction Price Per Share:
Value:  0.0
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Value:  1/3/21
Expiration Date:
Value:  1/2/24
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  42,525
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Footnotes:
Footnote - F1:  The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.30 to $51.60 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) on this Form 4.
Footnote - F2:  The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.07 to $50.75 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
Footnote - F3:  The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.75 to $50.50 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
Owner Signature:
Signature Name:  By: Patrick R. O'Neil, attorney-in-fact For: B. Lynne Parshall
Signature Date:  12/28/23


↑Top
Filing Submission 0000874015-23-000241   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., Apr. 28, 8:23:18.2pm ET